Volume 26, Issue 5 e14289
COMPREHENSIVE REVIEW

Extracorporeal membrane oxygenation and paracorporeal lung assist devices as a bridge to pediatric lung transplantation

Laura E. Chiel

Laura E. Chiel

Division of Pulmonary Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Zachary A. Winthrop

Zachary A. Winthrop

Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Francis Fynn-Thompson

Francis Fynn-Thompson

Department of Cardiac Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Levent Midyat

Corresponding Author

Levent Midyat

Division of Pulmonary Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Correspondence

Levent Midyat, Division of Pulmonary Medicine, Boston Children’s Hospital, 300 Longwood Avenue, BCH 3121, Boston, MA, 02115, USA.

Email: [email protected]

Search for more papers by this author
First published: 13 April 2022
Citations: 8

Abstract

Background

“Bridging” is a term used to describe the implementation of various treatment modalities to improve waitlist survival while a patient awaits lung transplantation. ECMO and PLAD are technologies used to bridge patients to lung transplantation. ECMO and PLAD are cardiopulmonary support systems that help move blood forward while using an artificial membrane to remove CO2 from and add O2 to the blood. Recent studies showed that these technologies are increasingly effective in bridging patients to lung transplantation, especially with optimizing patient selection, implementing physical rehabilitation and ambulation goals, standardization of management decisions, and increasing staff experience, among other considerations. We review these technologies, their roles as bridges to pediatric lung transplantation, as well as indications, contraindications, complications, and mortality rates.

Conclusion

Finally, we discuss the existing knowledge gaps and areas for future research to improve patient outcomes and understanding of lung assist devices.

CONFLICT OF INTEREST

The other authors have indicated they have no potential conflicts of interest to disclose.

DATA AVAILABILITY STATEMENT

There is no data statement for this review article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.